BioNTech SE ADR Stock
StockStockPrice
Frequently asked questions
What is BioNTech SE ADR's market capitalization?
What is the Earnings Per Share (EPS) for BioNTech SE ADR?
What are the analyst ratings and target price for BioNTech SE ADR's stock?
What is BioNTech SE ADR's revenue over the trailing twelve months?
What is the EBITDA for BioNTech SE ADR?
What is the free cash flow of BioNTech SE ADR?
What is the 5-year beta of BioNTech SE ADR's stock?
How many employees does BioNTech SE ADR have, and what sector and industry does it belong to?
What is the free float of BioNTech SE ADR's shares?
Financials
Market Cap
$26.51B5Y beta
0.22EPS (TTM)
-$2.269Free Float
214.95MRevenue (TTM)
$2.91BEBITDA (TTM)
-$568.79MFree Cashflow (TTM)
$2.55BPricing
Analyst Ratings
The price target is $114.43 and the stock is covered by 19 analysts.
Buy
8
Hold
9
Sell
2
Information
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
6,133
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker